These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1222942)

  • 1. Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies.
    Zatz M; Frota-Pessoa O; Peres CA
    Hum Hered; 1975; 25(5):354-9. PubMed ID: 1222942
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy.
    Emery AE; Holloway S
    Hum Hered; 1977; 27(2):118-26. PubMed ID: 863458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sex-linked muscular dystrophies].
    Diricq-Pierquin G; Lambotte C
    Rev Med Liege; 1983 Jan; 38(2):58-74. PubMed ID: 6342086
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.
    Skinner R; Emery AE; Anderson AJ; Foxall C
    J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Carrier detection in Duchenne type muscular dystrophy.
    Morgan G
    Aust N Z J Med; 1974 Apr; 4(2):196-7. PubMed ID: 4528526
    [No Abstract]   [Full Text] [Related]  

  • 10. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic counselling in lethal X-linked disorders.
    Emery AE; Morton R
    Acta Genet Stat Med; 1968; 18(6):534-42. PubMed ID: 4976958
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counselling in X-linked muscular dystrophy.
    Emery AE
    J Neurol Sci; 1969; 8(3):579-87. PubMed ID: 4185251
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic counselling in neuromuscular diseases in Western Australia.
    Hurse PV; Kakulas BA
    Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of Bayes theorum in genetic counseling in cases of Duchenne muscular dystrophy].
    Dodinval P
    J Genet Hum; 1979 Jun; 27(2):131-43. PubMed ID: 541678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial effect on serum creatine-kinase: implications for estimation of heterozygosity risks for females at-risk for Duchenne dystrophy.
    Passos-Bueno MR; Rabbi-Bortolini E; Azevêdo E; Zatz M
    Clin Chim Acta; 1989 Feb; 179(2):163-8. PubMed ID: 2920447
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and genetic counselling of subclinical and carrier states in Duchenne muscular dystrophy.
    Das PK; Sen SK
    Eur Neurol; 1979; 18(2):91-5. PubMed ID: 456392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.